Get the Stockscreener App
90.27
2.35%
-2.17
Twist Bioscience Corp stock is traded at $90.27, with a volume of 1.04M.
It is down -2.35% in the last 24 hours and down -1.18% over the past month.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
See More
Previous Close:
$92.44
Open:
$93.69
24h Volume:
1.04M
Relative Volume:
0.61
Market Cap:
$5.62B
Revenue:
$409.48M
Net Income/Loss:
$-81.28M
P/E Ratio:
-67.94
EPS:
-1.3286
Net Cash Flow:
$-95.14M
1W Performance:
-3.81%
1M Performance:
-1.18%
6M Performance:
+110.22%
1Y Performance:
+157.33%
1-Day Range:
$88.86
$94.50
1-Week Range:
$85.20
$97.45
52-Week Range:
$23.30
$105.47
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, IDXX, A, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
90.27 | 5.62B | 409.48M | -81.28M | -95.14M | -1.3286 |
TMO
Thermo Fisher Scientific Inc
|
568.26 | 211.18B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
191.50 | 134.62B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
544.32 | 42.94B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
138.57 | 39.14B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.99 | 37.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-25 | Initiated | Stephens | Overweight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience Corp (TWST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Twist Bioscience Corp (TWST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Twist Bioscience Corp (TWST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Twist Bioscience Corp (TWST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Twist Bioscience Corp (TWST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TWST|Twist Bioscience Corp|Price:90.180|Chg%:-2.260 - TradingKey
Twist Bioscience (TWST) Surged on Strong Results and AI Drug Discovery Demand - Yahoo Finance
Form 144 Twist Bioscience Corp For: 23 July By Investing.com - Investing.com Nigeria
Insider for TWST (NASDAQ: TWST) files Form 144 for stock sale - Stock Titan
ETFs Investing in Twist Bioscience Corp. Stocks - TradingView
Twist Bioscience Corp Investor Day Transcript - GuruFocus
Cathie Wood Is Selling This High-Flying Stock. Is It a Buy? - The Motley Fool
Lobbying Update: $82,500 of TWIST BIOSCIENCE CORPORATION lobbying was just disclosed - Quiver Quantitative
Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026 - Business Wire
TWST Maintained by Canaccord Genuity -- Price Target Raised to $120 - GuruFocus
Form 4 Twist Bioscience Corp For: 13 July By Investing.com - Investing.com Nigeria
Twist Bioscience CFO Adam Laponis sells $226,307 in stock By Investing.com - Investing.com Australia
Twist Bioscience CFO Adam Laponis sells $226,307 in stock - Investing.com
Twist Bioscience (TWST) CFO sells 2,399 shares for tax withholding - Stock Titan
Form 144 Twist Bioscience Corp For: 9 July By Investing.com - Investing.com Australia
Officer reports multiple common stock sales (NASDAQ: TWST) - Stock Titan
Evercore ISI Raises its Price Target on Twist Bioscience (TWST) - Insider Monkey
Twist Bioscience2026 Funding Rounds & List of Investors - Tracxn
Twist Bioscience stock falls as investors digest recent dilution risk and insider sale signals - Quiver Quantitative
TWST Downgraded by Evercore ISI Group -- Price Target Raised to $102 - GuruFocus
The Power of Complex Gene Synthesis - the-scientist.com
Investment bank Evercore ISI has adjusted its rating on biotechnology company Twist Bioscience Corp (TWST). - Bitget
TWSTTwist Bioscience Corp Options - Finviz
Twist Bioscience Corp. Actuals & Estimates (SWB:0ME) - TradingView
Twist Bioscience stock hits 52-week high at 104.31 USD By Investing.com - Investing.com South Africa
Twist Bioscience stock hits 52-week high at 104.31 USD - Investing.com
Cathie Wood’s ARK sells Twist Bioscience, buys Circle Internet stock - Investing.com
Cathie Wood’s ARK sells Twist Bioscience, buys Circle Internet stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK buys Coinbase, sells Twist Bioscience stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK buys Coinbase, sells Twist Bioscience stock - Investing.com
TWST Maintained by Guggenheim -- Price Target Raised to $107.00 - GuruFocus
Twist Bioscience Corp. Actuals & Estimates (NASDAQ:TWST) - TradingView
Form 4 Twist Bioscience Corp For: 26 June By Investing.com - Investing.com South Africa
Twist Bioscience CEO Emily Leproust sells $1.79m in stock By Investing.com - Investing.com Nigeria
Insider Sell: Dennis Cho Sells 14,205 Shares of Twist Bioscience Corp (TWST) - GuruFocus
Twist Bioscience CEO Emily Leproust sells $1.79m in stock - Investing.com
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Twist Bioscience Corp Stock (TWST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Laponis Adam | Chief Financial Officer |
Jul 09 '26 |
Sale |
94.33 |
2,399 |
226,307 |
110,276 |
0.02%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):